Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H31NO4 |
| Molecular Weight | 337.4537 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCOC1=C(OC)C=C(C=C1OC)C(N)=O
InChI
InChIKey=REYUZOLYIOQRIG-UHFFFAOYSA-N
InChI=1S/C19H31NO4/c1-4-5-6-7-8-9-10-11-12-24-18-16(22-2)13-15(19(20)21)14-17(18)23-3/h13-14H,4-12H2,1-3H3,(H2,20,21)
| Molecular Formula | C19H31NO4 |
| Molecular Weight | 337.4537 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://patents.google.com/patent/US3432549
Sources: https://patents.google.com/patent/US3432549
Decimemide is a spasmolytic and anticonvulsant derivative of benzamide, developed by the Hungarian E.G.Y.R Gyogyszervegyeszeti Gyar. The compound is claimed to effectively inhibit convulsion caused by chemoconvulsants or electric shock and to have a strong antiepileptic effect without showing any neurodepressant character.
CNS Activity
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:41:27 GMT 2025
by
admin
on
Wed Apr 02 08:41:27 GMT 2025
|
| Record UNII |
GAF9GJ18J5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2969
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
100000083451
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
GAF9GJ18J5
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
3127
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
C75162
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
DTXSID70163893
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL91688
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
m1102
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB06931MIG
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
14817-09-5
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY | |||
|
26929
Created by
admin on Wed Apr 02 08:41:27 GMT 2025 , Edited by admin on Wed Apr 02 08:41:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |